Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q2 2026 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2025 Net Income-$32.65M-$32.65MN/M vs Q2 2025 EPS Diluted-$1.26-$1.26N/M vs Q2 2025 Operating Income-$19,161,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$13,442,000N/M ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end